1. Home
  2. > Biotechnology
  3. > Genomics Proteomics and Enabling Technology Market Trends
Europe Transient Protein Expression Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type ; Application ; End User

Europe Transient Protein Expression Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type ; Application ; End User

  • May 2021
  • 155 pages
  • ID: 6075684
  • Format: PDF
  • The Insight Partners

Summary

Table of Contents

Search Inside

The Europe transient protein expression market is expected to reach US$ 245.9 million in 2027 from US$ 172.5 million in 2019. The market is estimated to grow with a CAGR of 4.7% from 2020-2027.

The market growth in this region is primarily attributed to factors such as the increasing applications of protein expression and growing adoption of precision medicines. However, the high cost of products limits the transient protein expression market growth.

Transient protein expression procedure has been widely in use for animal and plant cells for the last three decades.However, in the recent few years, significant evolution in proteomics has resulted in the development of recombinant proteins.

The effective results of transient protein expression in animals and plants have increased research and product development for human applications.Various companies, including biopharmaceuticals and contract research and development organizations have channelized their efforts toward the development of products based on transient protein expression-based products.

The adoption of transient protein expression allows companies to get various genes to develop recombinant proteins without delaying cell line generation.Thus, the quick process of cell line development with required gene expression, companies are widely attracted towards uniform proteins that have drug-like properties, which allows production of vaccines and viral vectors.

In addition, the transient protein expression process is widely being used in the production of monoclonal antibodies, modified human proteins, growth factors and cytokines, hormones, and blood products.

The COVID–19 pandemic has resulted in rise in the use of transient protein expression in vaccine development.Various researchers have started studying the novel coronavirus extensively, with the use of transient protein expression.

The transient protein expression was widely used to produce a positive control protein in the development of in-vitro diagnostics kits.

In transient expression mode, the protein is only expressed for short time, usually for 7–14 days.The process of antibodies production based on transient expression has improved remarkably in the last two decades with antibody yields increasing from low levels (mg/L) to the levels as high as 3 g/L.

Although the transient expression is often thought of as a preclinical research activity, it has been scaled up to at least 100 L.With modern g/L-level transient expression systems, this would represent a useful quantity of materials, whether it be for proof-of-concept clinical trials or IVD manufacturing.

Biotechnology companies are investing in research for COVID-19 vaccine development and testing.For instance, Merck KGaA, Germany, is supporting more than 50 potential COVID-19 vaccine development projects by supplying products and reagents for diagnostics, along with supporting the players engaged in investigating active pharmaceutical ingredients for the treatment of patients with Covid-19 pneumonia.

According to the quarterly report, sales of the Process Solutions business unit of Merck increased organically by 26.5% in the Q3 2020. Moreover, the Research Solutions business unit reported the organic revenue growth of 9.5%, partially due to the good business recovery following the operations resuming at academic laboratories after the first half of 2020. Moreover, the Research & Applied Solutions produced organic sales growth of 3.7%. Further, in December 2020, QIAGEN launched its QuantiFERON SARS-CoV-2 RUO solution that can detect the T-cell responses of human immune system to the SARS-CoV-2, which may help researchers learn more about immunity levels and disease progression.

In the long run, the demand for components required for transient protein expression in Europe is likely to increase with the rapidly prevalence of Covid -19 as well as other diseases such as cancer. The impact of the COVID-19 pandemic on the European transient protein expression market is high.

Based on product type, the Europe transient protein expression market is segmented into instruments, reagents, expression vectors, and competent cells. The instruments segment held the largest market share in 2019, whereas the expression vectors segment is anticipated to register the highest CAGR during the forecast period.

Based on application, the Europe transient protein expression market is segmented into genomic research, gene therapy, bio production, cancer research, and drug development. The genomic research segment held the largest market share in 2019, and it is estimated to register the highest CAGR during 2020–2027.

The Europe transient protein expression market, by end user, is segmented into pharmaceutical and biotechnology companies, academic and research institutes, and clinical research organizations. The pharmaceutical and biotechnology companies segment held the largest market share in 2019, and it is expected to register the highest CAGR during the forecast period.

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.

ReportLinker may already be registered as a supplier with your company. If you want to Order by PO, check with us first and we'll let you know if we are a registered supplier and what the vendor number is. Otherwise, we'll provide you with the necessary information to register ReportLinker as a vendor.

Grace helps you find the right report:
Testimonials

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at
Ikea

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at
Ingredion

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

FAQ
  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at [email protected] to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - [email protected] or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers

Label-Free Detection Market Research Report by Product, Technology, Application, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation - United States Forecast 2023-2030

  • $ 3949
  • January 2023
  • 152 pages

Label-Free Detection Market Research Report by Product (Consumables and Instruments), Technology, Application, End User, State - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and High Inflation ...

  • United States
  • Drug Development
  • Proteomics
  • Industry analysis

ref:plp2021

Reportlinker.com © Copyright 2023. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on